首页 | 官方网站   微博 | 高级检索  
     

治疗心房纤颤和扑动的新药决奈达隆
引用本文:吕娟丽,刘洋,李彦,刘振华.治疗心房纤颤和扑动的新药决奈达隆[J].药学实践杂志,2011,29(1):41-44.
作者姓名:吕娟丽  刘洋  李彦  刘振华
作者单位:武警总医院药剂科,北京,100039
摘    要:决奈达隆为胺碘酮的类似物,结构中不含碘,减少了碘所致的器官毒性,为新型的抗心律失常药。2009年7月1日获FDA批准,用于治疗心房纤颤或心房扑动的心脏病患者。本文通过对决奈达隆进行文献检索,对其药理作用、药动学、临床评价、药物相互作用、不良反应等方面进行了综述。

关 键 词:决奈达隆  心房纤颤  心房扑动  抗心律失常药
收稿时间:3/4/2010 12:00:00 AM
修稿时间:2010/3/11 0:00:00

Dronedarone a new drug for atrial fibrillation or atrial flutter
LV Juan-li,LIU Yang,Li Yan and Liu Zhen-hua.Dronedarone a new drug for atrial fibrillation or atrial flutter[J].The Journal of Pharmaceutical Practice,2011,29(1):41-44.
Authors:LV Juan-li  LIU Yang  Li Yan and Liu Zhen-hua
Affiliation:General Hospital of Chinese People's Armed Police Forces, Beijing 100039, China;General Hospital of Chinese People's Armed Police Forces, Beijing 100039, China;General Hospital of Chinese People's Armed Police Forces, Beijing 100039, China;General Hospital of Chinese People's Armed Police Forces, Beijing 100039, China
Abstract:Dronedarone is analogues as amiodarone, the structure is not iodine, reducing iodine-induced organ toxicity, is one of the new anti-arrhythmia drugs. on July 1, 2009 , It has been approved by FDA for the treatment of atrial fibrillation or atrial flutter in patients with heart disease. In this paper, after a literature search for Dronedarone with key words, the pharmacological , pharmacokinetics, clinical evaluation, drug interactions and adverse reactions of dronedarone are reviewed.
Keywords:dronedarone  atrial fibrillation  atrial flutter  anti-arrhythmia drugs
本文献已被 CNKI 维普 万方数据 等数据库收录!
点击此处可从《药学实践杂志》浏览原始摘要信息
点击此处可从《药学实践杂志》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司    京ICP备09084417号-23

京公网安备 11010802026262号